FIELD: organic chemistry, fungicides, pharmacy. SUBSTANCE: invention relates to pharmaceutical composition comprising the following components: 1) (-)-(2R-cis)-4-[4-[4- [4-[[5-(2,4-difluorophenyl)tetrahydro-5-(1H-1,2,4-triazole-1-ylmethyl)furan-3-yl] methoxy]phenyl]-1- piperazinyl]phenyl] -2,4-dihydro-2-(S)-hydroxypropyl] -3H-1,2,4-triazole-3-one as an antifungal agent; 2) at least one nonionic surface-active substance and 3) diluting agent. The composition confers to an antifungal compound with low water-soluble property the enhanced bioavailability in mammals including humans. EFFECT: improved and enhanced properties of composite. 19 cl, 16 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION OF S1P RECEPTOR AGONIST FOR TREATING DEMYELINIATING DISEASES | 2013 |
|
RU2530626C1 |
| RAPIDLY DISSOLVING PHARMACEUTICAL COMPOSITION | 1998 |
|
RU2203665C2 |
| STABLE PHARMACEUTICAL COMPOSITION OF WATER-SOLUBLE SALT OF VINORELBINE | 2008 |
|
RU2476208C2 |
| BENZAMIDE DERIVATIVE-CONTAINING PHARMACEUTICAL COMPOSITION ELICITING ENHANCED SOLUBILITY AND ABSORPTION CAPACITY IN ORAL APPLYING | 2000 |
|
RU2260428C2 |
| GLUCOSAMINE PROLONGED RELEASE DOSAGE FORM | 2011 |
|
RU2521231C2 |
| ORAL ANTITUMOUR DRUGS AND METHOD FOR ONCOLOGICAL DISEASES TREATMENT | 2016 |
|
RU2639479C1 |
| PHARMACEUTIC COMPOSITION CONTAINING OMAGACARBOXYARYL-SUBSTITUTED DIPHENYL UREA FOR CANCER TREATMENT | 2006 |
|
RU2420283C2 |
| SOLID PHARMACEUTICAL PREPARATION, METHOD OF ITS PREPARATION AND USE | 2021 |
|
RU2809722C1 |
| MEDICATION INTENDED FOR PERORAL INTRODUCTION CONTAINING CYCLOOXIGENASE-2 INHIBITOR AND METHOD OF OBTAINING IT | 2006 |
|
RU2391099C2 |
| PROPHEN-CONTAINING PHARMACEUTICAL MIXTURE | 1999 |
|
RU2240109C2 |
